We are a group of statisticians working at CROs and pharmaceutical industry supporting preclinical drug discovery on animal and cell based experiments. As a group, our focus is on diverse range of preclinical topics such as;
- Discovery
- Robust study design/good statistical practices in in-vitro, ex-vivo and in-vivo assay development
- Reproducibility and Translation from pre-clinical to clinical
- Toxicogenomics
- General Toxicology
- Eco-Toxicology
- Toxicokinetics
- DMPK / Pharmacokinetics
- ECG
- Immuno Toxicology
- Histopathology
- Pharmacology
- Developmental and Reproductive Toxicology
- Carcinogenicity
We organise webinars and workshops on topics and methodological developments in preclinical research and now have a list of over 50 affiliates on our e-mail distribution list.
Core Committee (L-R): (* not present in the picture)
Name | Company/Institution |
Denise Federico | Evotec |
Luc Essermeant | Sanofi |
Eloisa Brook | GSK (chair) |
Dorothee Tamarelle | Sanofi |
Fetene Tekle | Janssen |
Bernd Igl* | Boehringer Ingelheim |
Ezgi Tanriver-Ayder* | GSK |
Sarah Vandepaer* | GSK |
Helena Geys* | Janssen |
Purpose
We see our mission as bridging preclinical knowledge and expertise within the pharmaceutical industry and academia to provide a forum to collaborate, discuss and advance statistical topics related to Research, Discovery (including efficacy models), Regulatory and Investigative Toxicology/Safety Assessment. We also hope to encourage the development of relevant statistical methodologies and promote the involvement of statisticians in these areas.
Find out more about us and our objectives in our video overview: